South Korean Life Sciences Trend Analysis 2013

Financing value in South Korean Biotech (Therapeutics & Diagnostics) in 2013 more than doubled that of 2012, reaching a historical high value of 21.7 billion KRW (23.7 million USD). Click here to download South Korean Life Sciences Trend Analysis 2013 – 12 pages

Read more

German Life Sciences Trend Analysis 2013

In the past year, the German biotech sector experienced a modest growth with a 17% increase in Biotech Therapeutics companies and a 48% increase in total financing value. Click here to download German Life Sciences Trend Analysis 2013 – 12 pages

Read more

UK Life Sciences Trend Analysis 2013

From 2007 to 2012, the market witnessed a steady increase of biotech financing value in the UK. Moreover, the year 2012 almost doubled the financing value of 2011. Click here to download UK Life Sciences Trend Analysis 2013 – 12 pages

Read more

French Life Sciences Trend Analysis 2013

2012 saw a six-fold increase in total financing value to USD 150 M in unison with a substantial increase in total number of Biotech companies. Click here to download French Life Sciences Trend Analysis 2013 – 12 pages

Read more

Danish Life Sciences Trend Analysis 2013

The number of biotech companies in Denmark grew by a promising 11%. However, the Biotech financing dropped to USD 49 M in 2012, 57% decrease. Click here to download Danish Life Sciences Trend Analysis 2013 – 13 pages

Read more

Canadian Life Sciences Trend Analysis 2013

The Canadian Biotech sector grew in 2012 by a modest 3% – with increases mostly in diagnostics and in analytical services. However financing proved to be quite weak: Funding raised totalled only USD 67 M. Click here to download Canadian Life Sciences Trend Analysis 2013 12 – pages

Read more